Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.
3.
4.

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

Calais da Silva FE, Bono AV, Whelan P, Brausi M, Marques Queimadelos A, Martin JA, Kirkali Z, Calais da Silva FM, Robertson C.

Eur Urol. 2009 Jun;55(6):1269-77. doi: 10.1016/j.eururo.2009.02.016. Epub 2009 Feb 21.

PMID:
19249153
5.
6.
7.

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.

Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH.

J Clin Oncol. 2006 Mar 1;24(7):1112-8.

PMID:
16505431
8.

The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.

Sundström A, Seaman H, Kieler H, Alfredsson L.

BJOG. 2009 Jan;116(1):91-7. doi: 10.1111/j.1471-0528.2008.01926.x. Epub 2008 Nov 11.

9.

Incidence of venous thromboembolism and the impact on survival in breast cancer patients.

Chew HK, Wun T, Harvey DJ, Zhou H, White RH.

J Clin Oncol. 2007 Jan 1;25(1):70-6.

PMID:
17194906
10.

Fracture risk in Danish men with prostate cancer: a nationwide register study.

Abrahamsen B, Nielsen MF, Eskildsen P, Andersen JT, Walter S, Brixen K.

BJU Int. 2007 Oct;100(4):749-54.

11.
12.

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.

PMID:
9236553
13.

Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.

Ray JG, Mamdani MM, Yeo EL.

Thromb Haemost. 2002 Aug;88(2):205-9.

PMID:
12195690
14.

Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.

Duggan C, Marriott K, Edwards R, Cuzick J.

J Clin Oncol. 2003 Oct 1;21(19):3588-93.

PMID:
14512389
15.

Association between venous thromboembolism and perioperative allogeneic transfusion.

Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ.

Arch Surg. 2007 Feb;142(2):126-32; discussion 133.

PMID:
17309963
16.

Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.

Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson C, Watson RB, Gardiner RA.

BJU Int. 2002 Sep;90(4):427-32.

17.
18.

The long-term risk of cancer in patients with a first episode of venous thromboembolism.

Douketis JD, Gu C, Piccioli A, Ghirarduzzi A, Pengo V, Prandoni P.

J Thromb Haemost. 2009 Apr;7(4):546-51. doi: 10.1111/j.1538-7836.2008.03268.x. Epub 2008 Dec 22.

19.

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.

Pérez Gutthann S, García Rodríguez LA, Castellsague J, Duque Oliart A.

BMJ. 1997 Mar 15;314(7083):796-800.

Supplemental Content

Support Center